Title : Meropenem clinical pharmacokinetics.

Pub. Date : 1995 Apr

PMID : 7648757






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In comparison with imipenem, meropenem is relatively stable to hydrolysis by the enzyme dehydropeptidase I (DHP-I), thus precluding the need for coadministration with an inhibitor of DHP-I, such as cilastatin. Cilastatin dipeptidase 1 Homo sapiens
2 In comparison with imipenem, meropenem is relatively stable to hydrolysis by the enzyme dehydropeptidase I (DHP-I), thus precluding the need for coadministration with an inhibitor of DHP-I, such as cilastatin. Cilastatin dipeptidase 1 Homo sapiens
3 In comparison with imipenem, meropenem is relatively stable to hydrolysis by the enzyme dehydropeptidase I (DHP-I), thus precluding the need for coadministration with an inhibitor of DHP-I, such as cilastatin. Cilastatin dipeptidase 1 Homo sapiens